# Ribavirin

## Ribarin 200mg

| TAH Drug Code      | [ORIBA](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ORIBA)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | In combination with interferon α for the treatment of chronic hepatitis C in adult patients who are α-interferon-naive or who have relapsed following α-interferon therapy.                                                                                                                                                                                                                                                                                                                                                                                      |
| Dosing             | Adult >= 18 years 1000-1200 mg daily in 2 divided doses， in combination with interferon α soln for inj administered SC at a dose of 3MIU 3 times/wk. The recommended dose of ribavirin is based on body weight (consistent with food): 1000 mg per day for patients weighing < 75 kg and 1200 mg for weight >= 75 kg， and should be divided into twice daily doses.                                                                                                                                                                                            |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Contraindications  | History of severe pre-existing cardiac disease; haemoglobinopathies; severe， debilitating medical conditions; severe hepatic dysfunction or decompensated liver cirrhosis; autoimmune hepatitis or a history of autoimmune disease; pre-existing thyroid disease. Pregnancy & lactation.                                                                                                                                                                                                                                                                        |
| Adverse Effects    | Haemolysis， anaemia， neutropenia， dry mouth， hyperhidrosis， asthenia， chest pain， fatigue， fever， headache， flu-like symptoms， malaise， rigors， weight loss， dizziness， paresthesia， GI disturbances， arthralgia， myalgia， CNS effects， viral infection， cough， dyspnoea， pharyngitis， rhinitis， alopecia， pruritus， rash， dry skin， parageusia， blurred vision. Dermatologic: Pruritus， Rash Gastrointestinal: Indigestion， Loss of appetite， Nausea Hematologic: Neutropenia (8% to 40% ) Neurologic: Headache Other: Fatigue |
| Pregnancy          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| More Info          | [UpToDate](https://www.uptodate.com/contents/ribavirin-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |

